Mark I. van Berge Henegouwen
Amsterdam University Medical Centers, Amsterdam UMC Location University of Amsterdam
Papers
8
Total Citations
312
H-Index
7
About
Mark I. van Berge Henegouwen is a world-renowned upper gastrointestinal surgeon whose research has fundamentally reshaped the surgical management of esophageal cancer. His primary focus is the advancement of minimally invasive techniques, particularly the evolution from conventional minimally invasive esophagectomy (MIE) to robot-assisted minimally invasive esophagectomy (RAMIE). Dr. van Berge Henegouwen’s major contributions include leading the landmark ROBOT-2 trial (101 citations), a randomized controlled trial that rigorously compared RAMIE to standard MIE for esophageal adenocarcinoma, providing high-level evidence for robotic approaches. He also spearheaded the Upper GI International Robotic Association (UGIRA) registry, which has produced seminal multicenter studies (73 and 24 citations) defining worldwide techniques and outcomes for RAMIE, moving the field beyond single-center reports. With over 300 cumulative citations across his most influential works, his impact is profound. Notably, his comprehensive reviews on the evolution of surgical approaches (54 citations) and current standards for esophageal adenocarcinoma (22 citations) serve as essential references for trainees and researchers. Dr. van Berge Henegouwen’s work continues to set the global standard for innovation in esophageal cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3The evolution of surgical approach for esophageal cancer54 citations · 2018
- 4
- 5
- 6Laparoscopic surgery for gastro-esophageal acid reflux disease19 citations · 2013
- 7
- 8The Rise of Robot-Assisted Surgery in the Netherlands1 citations · 2025